These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7475904)

  • 1. Vasoactive intestinal peptide increases the liberation of arachidonate from anterior pituitary cells in vitro.
    Judd AM
    Life Sci; 1995; 57(18):1641-6. PubMed ID: 7475904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone and lysine-bradykinin stimulate arachidonate liberation from rat anterior pituitary cells through different mechanisms.
    Judd AM; MacLeod RM
    Endocrinology; 1992 Sep; 131(3):1251-60. PubMed ID: 1505463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II increases pituitary cell prolactin release and arachidonate liberation.
    Judd AM; Ross PC; Spangelo BL; MacLeod RM
    Mol Cell Endocrinol; 1988 May; 57(1-2):115-21. PubMed ID: 3135214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrularia thionin increases arachidonate liberation and prolactin and growth hormone release from anterior pituitary cells.
    Judd AM; Vernon LP; MacLeod RM
    Toxicon; 1992 Dec; 30(12):1563-73. PubMed ID: 1488765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
    Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
    Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha increases release of arachidonate and prolactin from rat anterior pituitary cells.
    Koike K; Hirota K; Ohmichi M; Kadowaki K; Ikegami H; Yamaguchi M; Miyake A; Tanizawa O
    Endocrinology; 1991 Jun; 128(6):2791-8. PubMed ID: 1903696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells in vitro.
    Bogacka I; Siawrys G; Okrasa S; Kaminski T; Przala J
    J Physiol Pharmacol; 2002 Sep; 53(3):439-51. PubMed ID: 12369740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
    Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
    Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
    Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
    Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
    Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J
    Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of vasoactive intestinal polypeptide and peptide histidine isoleucine on prolactin secretion by the bullfrog pituitary gland.
    Koiwai K; Kikuyama S; Seki T; Yanaihara N
    Gen Comp Endocrinol; 1986 Nov; 64(2):254-9. PubMed ID: 3493951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells: effects of dopaminergic drugs.
    Xu M; Proudman JA; Pitts GR; Wong EA; Foster DN; el Halawani ME
    Proc Soc Exp Biol Med; 1996 May; 212(1):52-62. PubMed ID: 8618952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
    Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
    Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonate stimulates prolactin release in vitro: a role for the fatty acid and its metabolites as intracellular regulator(s) in mammotrophs.
    Canonico PL; Judd AM; Koike K; Valdenegro CA; MacLeod RM
    Endocrinology; 1985 Jan; 116(1):218-25. PubMed ID: 2981065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of vasoactive intestinal peptide on insulin-like growth factor I-induced proliferation of rat pituitary lactotropes in primary culture: evidence for an autocrine and/or paracrine regulatory system.
    Fernández M; Sánchez-Franco F; Palacios N; Sánchez I; Villuendas G; Cacicedo L
    Neuroendocrinology; 2003 May; 77(5):341-52. PubMed ID: 12806180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stimulation of prolactin release by vasoactive intestinal peptide.
    Samson WK; Said SI; Snyder G; McCann SM
    Peptides; 1980; 1(4):325-32. PubMed ID: 7301635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.